6Evans DJ. The use of adjunctive corticosteroids in the treat- ment of pericardial, pleural and meningeal tuberculosis: do they improve outcome? Respir Med, 2008,102(6) : 793-800.
7Simmons CP, Thwaites GE, Quyen NT, et al. The clinical bene- fit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or im-mune responses. J Immunol,2005, 175(1):579-590.
8Fitch MT, van de Beek D. Drug Insight: steroids in CNS infec- tious diseases-- new indications for an old therapy. Nat Clin Pract Neurol, 2008,4(2): 97-104.
9McGee S, Hirschmann J. Use of corticosteroids in treating in- fectious diseases. Arch Intern Med, 2008, 168 ( 10 ): 1034-1046.
1Flavell S, Eder M, Beaton RK, et al. Extensively drug resistant tuberculosis in a HIV-infected patient in a UK hospital. Int J STD AIDS ,2013,24:63-66.
2Alsleben N, Garcia-Prats A J, Hesseling AC, et al. Successful treatment of a child with extensively drug-resistant tuberculous meningitis. J Pediatric Infect Dis Soc, 2015,4 : e41 -e44.
3Liao PW, Chiang TR, Lee MC, et al. Tuberculosis with meningitis, myeloradiculitis, arachnoiditis and hydrocephalus: a case report. Acta Neurol Taiwan ,2010,19 : 189-193.
4Pehlivanoglu F,Yasar KK,Sengoz G. Tuberculous meningitis in adults: a review of 160 cases. Scientific World J ,2012,2012:169028.
5Gulefia R, Kaviha. Central nervous system tuberculosis. Indian J Tuberc, 2014,61:195-199.
6Maclean KA, Becker AK, Chang SD, et al. Extrapulmonary ruberculosis:imaging features beyond the chest. Can Assoc Radiol J,2013,64:319-324.
7World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTbl/TB/2014. 11. Geneva: World Health Organization, 2014.
